2013
DOI: 10.1186/scrt223
|View full text |Cite
|
Sign up to set email alerts
|

Topical administration of orbital fat-derived stem cells promotes corneal tissue regeneration

Abstract: IntroductionTopical administration of eye drops is the major route for drug delivery to the cornea. Orbital fat-derived stem cells (OFSCs) possess an in vitro corneal epithelial differentiation capacity. Both the safety and immunomodulatory ability of systemic OFSC transplantation were demonstrated in our previous work. In this study, we investigated the safety, therapeutic effect, and mechanism(s) of topical OFSC administration in an extensive alkali-induced corneal wound.MethodsCorneal injury was created by … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
73
0
18

Year Published

2015
2015
2019
2019

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 67 publications
(98 citation statements)
references
References 34 publications
7
73
0
18
Order By: Relevance
“…The multi-lineage differentiation capacity of OASCs has shown great therapeutic potential in the field of ophthalmology and regenerative medicine [69]. Because such promising applications involve the treatment of diseases and conditions found in an aging population, hindered by stem cell senescence and dysfunction in the natural aging process, the donor or patient age must be accounted for before the autologous stem-cell-based therapeutics entering the clinic.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The multi-lineage differentiation capacity of OASCs has shown great therapeutic potential in the field of ophthalmology and regenerative medicine [69]. Because such promising applications involve the treatment of diseases and conditions found in an aging population, hindered by stem cell senescence and dysfunction in the natural aging process, the donor or patient age must be accounted for before the autologous stem-cell-based therapeutics entering the clinic.…”
Section: Discussionmentioning
confidence: 99%
“…The existence of human orbital adipose-derived stem cells (OASCs) also has been proven. In addition to differentiating into adipocytes, chondrocytes and osteoblasts, these cells also can differentiate towards the corneal epithelial, smooth muscle and neuronal lineages under specific inductive conditions, showing great therapeutic potential in treating the orbital and ocular diseases [69]. …”
Section: Introductionmentioning
confidence: 99%
“…were tried as alternative sources of autologous stem cell-based therapy for corneal diseases and wound healing (Ono et al 2007; Yang et al, 2008; Kumagai et al, 2010; Meyer-Blazejewska, et al 2011; Yan et al, 2014). Adipose-derived, orbital fat-derived, and immature dental pulp stem cells have been used for successful re-epithelialization of chemically burned cornea (Monteiro et al, 2009; Lin et al, 2013b; Zeppieri et al, 2013). Additionally, mesenchymal stem cells (MSCs) were also considered as a source of corneal cells to treat burns and LSCD (Ma et al, 2006; Reinshagen et al, 2011; Pinarli et al, 2014).…”
Section: Corneal Epithelial Wound Healingmentioning
confidence: 99%
“…Orbital fat-derived stem cells (OFSCs) are MSCs isolated from human orbital fat tissue [14] and their therapeutic effects on acute tissue injury have been demonstrated via paracrine tissue support, immunomodulation, and differentiation ability in our previous experimental studies [15][16][17]. In this study, rats received surgery with 720°of unilateral testicular torsion for 3 hours, and local injection of OFSCs 30 minutes before surgical detorsion was performed.…”
Section: Introductionmentioning
confidence: 99%